PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair

Core Viewpoint - PetMed Express, Inc. has appointed James LaCamp to its Board of Directors, effective immediately, and he will become Chair of the Audit Committee on October 30, 2025, enhancing the company's financial governance and oversight capabilities [2][3]. Board Composition and Changes - The appointment of James LaCamp is part of PetMed's ongoing board refreshment strategy, which aims to build a board of independent and highly qualified directors to support profitable revenue growth and shareholder value creation [3][4]. - Since fiscal Q4 2024, notable changes to the board include Leslie C. G. Campbell becoming Chair of the Board, and the appointments of Justin Mennen, Leah Solivan, and Peter Batushansky, resulting in a board of six directors, five of whom are independent [3][4]. James LaCamp's Background - James LaCamp brings nearly 20 years of experience in finance, accounting, and corporate strategy, having served as Chief Financial Officer at various technology companies and as an Audit Partner at Deloitte & Touche LLP [5][6][7]. - Currently, LaCamp is the Chief Financial Officer of Skydio, overseeing all financial operations, and has held leadership roles in other technology firms, contributing to financial strategy and operations [7][8]. Company Overview - PetMed Express, founded in 1996, is a pioneer in the direct-to-consumer pet healthcare sector, offering a range of pet health solutions through its online pharmacy, licensed across all 50 states [10]. - The company focuses on value, convenience, and care, empowering pet parents to support the health of their pets [10].